SG
Insider
Steven Gannon
DirectorSteven Gannon (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Xenon Pharmaceuticals Inc. (XENE). The largest single filing was $641K of XENE (10,000 sh × $64.06, as filed), executed Aug 11.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$641K
shares × price, as filed
Last traded
Aug 11
Filed Aug 13
Median ADV $85.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $641K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
XENERecent filings
XENESALE
Xenon Pharmaceuticals Inc.
View filing →
$641K10,000 sh × $64.06
Exec Aug 11
Filed Aug 13 · 4:33 PM ET